NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) announced today that the company will participate in the Planet MicroCap Las Vegas 2026 Conference, scheduled for June 17-18, 2026. Dave Rosa, President and Chief Executive Officer, will attend the conference in Las Vegas, Nevada, where he is set to host one-on-one meetings with institutional investors and deliver a company presentation.
The presentation is scheduled for Wednesday, June 17, 2026, at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern Time in TRACK 6 - Raphael 3. During the presentation, Mr. Rosa will provide commercialization updates and anticipated milestones for the OneRF platform, which is designed for treatment of the brain, pain, and advanced drug delivery. A webcast of the presentation will be available here.
In addition to the live presentation, Mr. Rosa participated in a CEO interview with Planet MicroCap host Robert Kraft ahead of the conference. The interview can be viewed here. The company's participation in this conference underscores its commitment to engaging with the investment community and highlighting its progress in the medical technology space.
NeuroOne is a medical technology company focused on improving surgical care options and outcomes for patients with neurological disorders. The company markets a minimally invasive electrode technology platform with four FDA-cleared product families: Evo Cortical Electrodes, Evo sEEG Electrodes, OneRF Ablation System (for brain), and OneRF Trigeminal Nerve Ablation System. These solutions aim to reduce hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering both diagnostic and therapeutic capabilities.
The company is also engaged in research and development for drug delivery, basivertebral nerve ablation, and spinal cord stimulation programs. For more information about NeuroOne, visit nmtc1.com.
The Planet MicroCap Las Vegas 2026 Conference provides a platform for small-cap companies to present their investment theses to institutional investors. NeuroOne's presentation is expected to highlight recent milestones and future growth opportunities, particularly around the OneRF platform, which represents a significant advancement in neurosurgical care.
